In:
Journal of Clinical Medical Research, Athenaeum Scientific Publishers, Vol. 03, No. 03 ( 2022)
Abstract:
Objective: through the present study, we try to evaluate the functional outcomes after scapulectomy with glenohumeral joint preservation for no metastatic primary malignant tumors of the scapula. Material and Methods: This retrospective study included 9 patients with no metastatic primary malignant tumors of the scapula treated in the Trauma-Orthopedic department B4 of Hassan II teaching hospital in Fez-Morocco between 2012 and 2021. The average age of the series was 36 years (range 25-42 years). The histological diagnosis was chondrosarcomas in the majority of our patients. The functional outcome and the emotional acceptance were evaluated according to the Musculoskeletal Tumor Society scoring system. Our working approach was carried out in total accordance with the Helsinki Declaration. Results: We found 9 patients with no metastatic primary malignant tumors of the scapula who were treated by the same surgical team and followed postoperatively in consultation for 36 months (range 18-48 months) an average. During surgery and postoperatively, no major complications were occurred. The mean of the Musculoskeletal Tumor Society score was 16.7 (56%). The mean emotional acceptance score was 2.8 (56%). Concerning oncological outcomes, continuously disease-free status was achieved in all cases at the last follow-up. Conclusions: Primary malignant tumors of the scapula can be treated successfully by scapulectomy with glenohumeral joint preservation. This procedure constitutes in the case of unavailability of scapular prosthesis and bone bank as in our context a reliable therapeutic option.
Type of Medium:
Online Resource
ISSN:
2582-6751
DOI:
10.46889/JCMR.2022.3302
Language:
Unknown
Publisher:
Athenaeum Scientific Publishers
Publication Date:
2022
